Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07406490 · ClinicalTrials.gov registry record
Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System
A clinical trial, sponsored by University of Florida.
- Not yet
- Registry status
- 6,466
- Enrollment target
NCT07406490: Clinical Trial study, sponsored by University of Florida.
NCT07406490 is a clinical trial that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 6,466 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07406490 has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- 6,466 participants
- Enrollment target
Study Summary
The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) screening tool for use in emergency departments (EDs) to identify patients at high risk of hepatitis C virus (HCV) infection. HepC-EnD will be integrated into the University of Florida Health electronic health record (EHR) system as a best practice alert (BPA) pop-up for ED providers, notifying them of patients at high risk for HCV infection and recommending both HCV and human immunodeficiency virus (HIV) screening. Investigators aim to enhance the screening and diagnosis of individuals who may otherwise remain undiagnosed and untreated. The implementation outcomes (e.g., usability) and effectiveness outcomes (e.g., HCV screening and diagnosis rates) of HepC-EnD targeted screening will be compared with universal screening (FOCUS) and conventional physician-initiated screening programs in EDs.
Primary Outcome
Proportion of positive results among performed tests. HCV diagnosis is defined as a positive RNA test result. HIV diagnosis is defined as an acute (i.e., antigen positive but antibody negative) or established (i.e., antibody positive) infection.
Interventions
- OTHER Physician-Initiated Screening (Conventional Screening)
- OTHER FOCUS (Universal Screening)
- OTHER HepC-EnD (Targeted Screening)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,466 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-07 |
What is known before NCT07406490 opens enrollment
NCT07406490 is an observational study that tracks outcomes without assigning an intervention. Its 6,466 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Physician-Initiated Screening (Conventional Screening) is the first listed.
NCT07406490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07406490 about?
NCT07406490 is a clinical study titled "Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System". The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) screening tool for use in emergency departments (EDs) to identify patients at high risk of hepatitis C virus (HCV) infection. HepC-EnD will be in...
What is the current status of trial NCT07406490?
This trial is currently not yet recruiting. The enrollment target is 6,466 participants. The study started on 2026-07-01. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07406490?
The interventions under investigation include: Physician-Initiated Screening (Conventional Screening) (OTHER), FOCUS (Universal Screening) (OTHER), HepC-EnD (Targeted Screening) (OTHER).
Who is sponsoring clinical trial NCT07406490?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI